Washington, D.C.
Dec 23, 2014
- Commercial Litigation
- Criminal and forfeiture defense alleging int’l money laundering and unlicensed money transmitting business
- Administrative litigation FDA alleging misbranding and adulterating autologous stem cells
- Civil litigation against US involving allegations of Tucker Act violations